サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1756457

包括的代謝パネル（CMP）検査市場：分析項目別、疾患別、最終用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測

Comprehensive Metabolic Panel (CMP) Testing Market, By Analytes, By Disease, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 378 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
包括的代謝パネル（CMP）検査市場：分析項目別、疾患別、最終用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2025年05月23日
発行: AnalystView Market Insights
ページ情報: 英文 378 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

包括的代謝パネル（CMP）検査市場規模は2024年に126億4,500万米ドルとなり、2024～2032年にかけてCAGR 9.4％で拡大

包括的代謝パネル（CMP）検査市場-市場力学

予防ヘルスケアへの需要の高まり

予防ヘルスケア重視の高まりは、包括的代謝パネル（CMP）検査市場の主要促進要因です。早期診断と疾病管理に対する意識の高まりに伴い、患者と医療提供者の双方が定期的な健康診断を優先するようになっています。臓器機能と代謝の健康状態を幅広く概要できるCMP検査は、症状が現れる前に潜在的な健康問題を特定するための不可欠なツールになりつつあります。さらに、糖尿病、腎臓病、肝臓疾患などの慢性疾患の有病率の増加が、需要をさらに促進しています。予防検診に対する政府の取り組みや保険適用も、市場の拡大に寄与しています。

包括的代謝パネル（CMP）検査市場-主要な洞察

弊社の調査アナリストによると、世界の包括的代謝パネル（CMP）検査市場は、2024～2032年にかけて約9.4%のCAGRで開発されると予測されています。

2024年の分析項目別セグメントでは、グルコースカテゴリが市場を独占しています。

疾患別では、2024年に最も収益を上げたのは糖尿病でした。

地域別では、2024年に北米が最も収益を上げた地域でした。

包括的代謝パネル（CMP）検査市場-セグメンテーション分析

世界の包括的代謝パネル（CMP）検査市場は4つのカテゴリーに分類されます：分析項目、疾患、最終用途、地域です。

分析物別では、包括的代謝パネル（CMP）検査市場は、カリウム（K+）、ナトリウム（Na+）、塩化物（Cl-）、二酸化炭素（CO2）、グルコース、血中尿素窒素（BUN）、クレアチニン、カルシウム（Ca2+）、アルブミン、総タンパク質、アルカリホスファターゼ（ALP）、アラニンアミノトランスフェラーゼ（ALT）、アスパラギン酸アミノトランスフェラーゼ（AST）、総ビリルビンに区分されます。これらのうち、糖尿病と糖尿病予備軍の世界の増加により、グルコース検査が市場を独占しています。血糖値の異常を早期に発見することは、代謝異常の管理と合併症の予防に不可欠です。そのため、グルコース分析は定期検診と疾患特異的スクリーニングの両方に含まれるのが一般的です。また、ポイントオブケア検査や在宅モニタリングの需要が高まっていることも、グルコース検査の頻度や利用しやすさの向上に寄与しており、CMP分析項目における市場でのリーダーシップをさらに強化しています。

疾患別では、包括的代謝パネル（CMP）検査市場は腎臓疾患、肝臓疾患、糖尿病、その他に区分されます。なかでも糖尿病は、その広範な有病率と、この疾患に関連する世界の健康負担の増大が主要理由であり、主要なセグメントとなっています。CMP検査は、血糖値を評価し、腎臓や肝臓など糖尿病の影響を受ける臓器機能を評価することで、糖尿病の診断とモニタリングに重要な役割を果たしています。座りがちなライフスタイル、食生活の乱れ、人口の高齢化などにより、2型糖尿病の罹患率が増加しているため、日常的な代謝評価の必要性が高まっています。さらに、早期発見と予防医療を推進する啓発キャンペーンや政府のヘルスケアプログラムが、糖尿病管理におけるCMP検査の需要をさらに押し上げています。

包括的代謝パネル（CMP）検査市場-地理的洞察

地域的には、包括的代謝パネル（CMP）検査市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米が包括的代謝パネル（CMP）検査市場を独占しているのは、先進的ヘルスケアインフラ、高いヘルスケア支出、予防医療の普及によるものです。特に米国は、糖尿病、腎障害、肝疾患などの慢性疾患の有病率が高く、大きく貢献しています。定期的な健康診断と強力な保険適用が、CMP検査の需要をさらに押し上げています。さらに、大手診断検査機関の存在と、病気の早期発見に対する一般市民の意識の高まりが、重要な役割を果たしています。ヘルスケアプロバイダによる戦略的イニシアティブと政府の好意的な施策が、世界のCMP検査市場における北米のリーダーシップを強化しています。

アジア太平洋は、慢性疾患の罹患率の上昇とヘルスケア意識の高まりにより、CMP検査市場の主要成長地域として浮上しています。中国、インド、日本などの国々では、急速な都市化、ライフスタイルの変化、中流階級の人口拡大により、診断検査に対する需要が急増しています。この地域の政府はヘルスケアインフラに投資し、予防医療プログラムを推進しており、これが市場の成長を支えています。さらに、公的・私的ヘルスケアの拡大により、診断サービスの利用しやすさ、利用しやすさが向上しています。これらの要因が相まって、アジア太平洋はCMP検査において最も有望な市場の一つとなっています。

包括的代謝パネル（CMP）検査市場-競合情勢

CMP検査市場は、アボット、クエスト・ダイアグノスティックス、ラボラトリー・コーポレーション・オブ・アメリカ・ホールディングス（LabCorp）、ソニックヘルスケアといった定評ある診断企業によって支配されています。これらの企業は、高い精度と信頼性を備えた幅広い代謝・生化学検査を提供しています。研究開発と先端診断技術への多額の投資は、規制遵守と製品革新の維持に役立っています。新規参入企業は、診断スピードとアクセシビリティを高めるため、AIとポイントオブケア検査の統合に注力しています。この競合環境は、検査効率、精度、利便性の継続的な向上を促し、臨床と予防医療におけるCMP検査の世界の普及を支えています。

目次

第1章 包括的代謝パネル（CMP）検査市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 包括的代謝パネル（CMP）検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 包括的代謝パネル（CMP）検査産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 包括的代謝パネル（CMP）検査市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 包括的代謝パネル（CMP）検査市場情勢

  • 包括的代謝パネル（CMP）検査市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • ベテラン選手の分析
    • 新興企業の分析

第7章 包括的代謝パネル（CMP）検査市場-分析項目別

  • 概要
    • 分析項目別セグメントシェア分析
    • K+
    • ナトリウム
    • Cl-
    • CO2
    • グルコース
    • BUN
    • クレアチニン
    • カルシウム
    • アルブミン
    • 総タンパク質
    • ALP
    • ALT
    • AST
    • 総ビリルビン

第8章 包括的代謝パネル（CMP）検査市場-疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • 腎臓病
    • 肝臓疾患
    • 糖尿病
    • その他

第9章 包括的代謝パネル（CMP）検査市場-最終用途別

  • 概要
    • 最終用途別セグメントシェア分析
    • ラボ
      • 救急科
      • 病院の病棟
      • プライマリケア
      • 薬局
      • 遠隔医療
    • 概念実証
      • 救急科
      • 病院の病棟
      • プライマリケア
      • 薬局
      • 遠隔医療
    • PoC（機器）
      • ピッコロエクスプレス
      • スカイラ-HB1
      • ドライケムNX500
      • その他

第10章 包括的代謝パネル（CMP）検査市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-包括的代謝パネル（CMP）検査産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott
    • Quest Diagnostics
    • Laboratory Corporation of America Holdings Limited
    • Sonic Healthcare
    • Unipath
    • SYNLAB International GmbH
    • ARUP Laboratories
    • Genoptix Inc.
    • Nova Medical
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV5325

REPORT HIGHLIGHT

Comprehensive Metabolic Panel (CMP) Testing Market size was valued at USD 12,645 Million in 2024, expanding at a CAGR of 9.4% from 2024 to 2032.

A Comprehensive Metabolic Panel (CMP) is a blood test that measures 14 different substances in the blood to provide information about the body's chemical balance and metabolism. It helps evaluate organ function, especially the liver and kidneys, and monitors conditions such as diabetes, liver disease, and electrolyte imbalances. The CMP includes tests for glucose, calcium, electrolytes (sodium, potassium, carbon dioxide, chloride), kidney function markers (BUN, creatinine), and liver enzymes (ALP, ALT, AST, bilirubin, albumin, total protein). Often part of routine health checkups, it aids in early detection and ongoing monitoring of various health conditions to support timely medical intervention.

Comprehensive Metabolic Panel (CMP) Testing Market- Market Dynamics

Growing Demand for Preventive Healthcare

The rising emphasis on preventive healthcare is a major driver of the Comprehensive Metabolic Panel (CMP) testing market. With increasing awareness about early diagnosis and disease management, both patients and healthcare providers are prioritizing routine health checkups. CMP tests, which offer a broad overview of organ function and metabolic health, are becoming essential tools for identifying potential health issues before symptoms appear. Additionally, the growing prevalence of chronic conditions such as diabetes, kidney disease, and liver disorders is further fueling demand. Government initiatives and insurance coverage for preventive screenings are also contributing to the market's expansion.

Comprehensive Metabolic Panel (CMP) Testing Market- Key Insights

According to our research analyst, the global Comprehensive Metabolic Panel (CMP) Testing Market is expected to develop at a CAGR of approximately 9.4% between 2024-2032.

Segmented by Analytes in 2024, the Glucose category dominated the market.

Based on Disease, the Diabetes segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Comprehensive Metabolic Panel (CMP) Testing Market- Segmentation Analysis:

The global Comprehensive Metabolic Panel (CMP) Testing Market is divided into Four categories: Analytes, Disease, End-use, and Region.

By analytes, the Comprehensive Metabolic Panel (CMP) testing market is segmented into potassium (K+), sodium (Na+), chloride (Cl-), carbon dioxide (CO2), glucose, blood urea nitrogen (BUN), creatinine, calcium (Ca2+), albumin, total protein, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin. Among these, glucose testing dominates the market due to the global rise in diabetes and prediabetes cases. Early detection of abnormal blood sugar levels is critical in managing metabolic disorders and preventing complications. As a result, glucose analysis is commonly included in both routine checkups and disease-specific screenings. The increasing demand for point-of-care testing and home-based monitoring also contributes to the higher frequency and accessibility of glucose testing, further strengthening its market leadership within CMP analytes.

By disease, the Comprehensive Metabolic Panel (CMP) testing market is segmented into kidney diseases, liver diseases, diabetes, and others. Among these, diabetes is the dominant segment, primarily due to its widespread prevalence and the growing global health burden associated with the condition. CMP tests play a critical role in diagnosing and monitoring diabetes by evaluating blood glucose levels and assessing organ functions affected by the disease, such as the kidneys and liver. The increasing incidence of type 2 diabetes, driven by sedentary lifestyles, poor dietary habits, and aging populations, has heightened the need for routine metabolic assessments. Moreover, awareness campaigns and government healthcare programs promoting early detection and preventive care have further propelled the demand for CMP testing in diabetes management.

Comprehensive Metabolic Panel (CMP) Testing Market- Geographical Insights

Geographically, the Comprehensive Metabolic Panel (CMP) Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America dominates the Comprehensive Metabolic Panel (CMP) testing market due to its advanced healthcare infrastructure, high healthcare spending, and widespread adoption of preventive care practices. The United States, in particular, contributes significantly with a high prevalence of chronic conditions such as diabetes, kidney disorders, and liver diseases. Regular health screening and strong insurance coverage further drive the demand for CMP tests. Additionally, the presence of leading diagnostic laboratories and increased public awareness about early disease detection play crucial roles. Strategic initiatives by healthcare providers and favorable government policies reinforce North America's leadership in the global CMP testing market.

Asia Pacific is emerging as a key growth region in the CMP testing market, driven by the rising incidence of chronic diseases and increasing healthcare awareness. Countries like China, India, and Japan are experiencing a surge in demand for diagnostic testing due to rapid urbanization, changing lifestyles, and expanding middle-class populations. Governments in the region are investing in healthcare infrastructure and promoting preventive health programs, which support market growth. Furthermore, the affordability and accessibility of diagnostic services are improving through both public and private healthcare expansions. These factors collectively position Asia Pacific as one of the most promising markets for CMP testing.

Comprehensive Metabolic Panel (CMP) Testing Market- Competitive Landscape:

The CMP testing market is dominated by established diagnostic firms such as Abbott, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Sonic Healthcare. These companies offer a broad range of metabolic and biochemical tests with high accuracy and reliability. Heavy investments in R&D and advanced diagnostic technologies help maintain regulatory compliance and product innovation. New entrants focus on integrating AI and point-of-care testing to enhance diagnostic speed and accessibility. This competitive environment drives continuous advancements in testing efficiency, accuracy, and convenience, supporting wider adoption of CMP testing in clinical and preventive healthcare settings globally.

Recent Developments:

In March 2024, Abbott launched a next-generation point-of-care blood analyzer designed for rapid metabolic panel testing, improving turnaround time and accessibility in remote healthcare settings.

In January 2025, Quest Diagnostics expanded its laboratory services by opening a state-of-the-art testing facility in Texas, boosting capacity for metabolic and genetic testing to meet rising demand.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Quest Diagnostics
  • Laboratory Corporation of America Holdings Limited
  • Sonic Healthcare
  • Unipath
  • SYNLAB International GmbH
  • ARUP Laboratories
  • Genoptix Inc.
  • Nova Medical
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY ANALYTES - MARKET ANALYSIS, 2019 - 2032

  • K+
  • Na+
  • Cl-
  • CO2
  • Glucose
  • BUN
  • Creatinine
  • Ca++
  • Albumin
  • Total Protein
  • ALP
  • ALT
  • AST
  • Total Bilirubin

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY DISEASE - MARKET ANALYSIS, 2019 - 2032

  • Kidney Diseases
  • Liver Diseases
  • Diabetes
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Laboratories
  • Emergency Departments
  • Hospital Wards
  • Primary Care
  • Pharmacy
  • Telemedicine
  • PoC
  • Emergency Departments
  • Hospital Wards
  • Primary Care
  • Pharmacy
  • Telemedicine
  • PoC (Instruments)
  • Piccolo Xpress
  • Skyla-HB1
  • DRI-CHEM NX500
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Comprehensive Metabolic Panel (CMP) Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Analytes
    • 2.1.2. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Disease
    • 2.1.3. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by End Use
    • 2.1.4. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Country
    • 2.1.5. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Comprehensive Metabolic Panel (CMP) Testing Key Market Trends

  • 3.1. Comprehensive Metabolic Panel (CMP) Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Comprehensive Metabolic Panel (CMP) Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Comprehensive Metabolic Panel (CMP) Testing Market Opportunities
  • 3.4. Comprehensive Metabolic Panel (CMP) Testing Market Future Trends

4. Comprehensive Metabolic Panel (CMP) Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Comprehensive Metabolic Panel (CMP) Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Comprehensive Metabolic Panel (CMP) Testing Market Landscape

  • 6.1. Comprehensive Metabolic Panel (CMP) Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Comprehensive Metabolic Panel (CMP) Testing Market - By Analytes

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Analytes, 2023 & 2032 (%)
    • 7.1.2. K+
    • 7.1.3. Na+
    • 7.1.4. Cl-
    • 7.1.5. CO2
    • 7.1.6. Glucose
    • 7.1.7. BUN
    • 7.1.8. Creatinine
    • 7.1.9. Ca++
    • 7.1.10. Albumin
    • 7.1.11. Total Protein
    • 7.1.12. ALP
    • 7.1.13. ALT
    • 7.1.14. AST
    • 7.1.15. Total Bilirubin

8. Comprehensive Metabolic Panel (CMP) Testing Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 8.1.2. Kidney Diseases
    • 8.1.3. Liver Diseases
    • 8.1.4. Diabetes
    • 8.1.5. Others

9. Comprehensive Metabolic Panel (CMP) Testing Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 9.1.2. Laboratories
      • 9.1.2.1. Emergency Departments
      • 9.1.2.2. Hospital Wards
      • 9.1.2.3. Primary Care
      • 9.1.2.4. Pharmacy
      • 9.1.2.5. Telemedicine
    • 9.1.3. PoC
      • 9.1.3.1. Emergency Departments
      • 9.1.3.2. Hospital Wards
      • 9.1.3.3. Primary Care
      • 9.1.3.4. Pharmacy
      • 9.1.3.5. Telemedicine
    • 9.1.4. PoC (Instruments)
      • 9.1.4.1. Piccolo Xpress
      • 9.1.4.2. Skyla-HB1
      • 9.1.4.3. DRI-CHEM NX500
      • 9.1.4.4. Others

10. Comprehensive Metabolic Panel (CMP) Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Comprehensive Metabolic Panel (CMP) Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Quest Diagnostics
    • 11.2.3. Laboratory Corporation of America Holdings Limited
    • 11.2.4. Sonic Healthcare
    • 11.2.5. Unipath
    • 11.2.6. SYNLAB International GmbH
    • 11.2.7. ARUP Laboratories
    • 11.2.8. Genoptix Inc.
    • 11.2.9. Nova Medical
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us